Ingredient monitoring plays a critical role in cosmetic safety assessment and regulatory compliance. This requirement becomes even more important within dynamic regulatory systems such as the European Union. Manufacturers and Responsible Persons must actively track changes in the safety profile, permitted uses, and legal status of every ingredient used in cosmetic formulations.
Effective ingredient monitoring depends on continuous access to reliable regulatory sources, updated toxicological data, and authoritative safety information. This proactive approach helps companies maintain compliance and protect consumer health.
Official Regulatory Databases as the Basis of Compliance
Government-backed regulatory databases define the legal status of cosmetic ingredients and serve as the foundation of compliance activities. These sources allow companies to verify whether substances are permitted, restricted, or prohibited.
The COSING database, maintained by the European Commission, lists all cosmetic ingredients regulated under the EU Cosmetic Regulation (EC) No 1223/2009. It reflects the content of all regulatory annexes, including prohibited substances, restricted ingredients, preservatives, colorants, and UV filters. COSING remains the primary reference tool for confirming cosmetic ingredient compliance in the EU.
Databases maintained by the European Chemicals Agency (ECHA) also support ingredient monitoring. Although ECHA focuses on REACH and CLP regulations, its Classification and Labelling Inventory helps identify newly classified CMR substances. Any new CMR classification can trigger an automatic ban in cosmetic products, making regular review essential.
Scientific Opinions and Toxicological Safety Data
Legal compliance alone does not establish ingredient safety. Manufacturers must also rely on scientific evaluations to support safety assessments and Product Information Files.
The Scientific Committee on Consumer Safety (SCCS) provides independent scientific opinions on cosmetic ingredients. These opinions explain the toxicological basis for regulatory decisions, including concentration limits, usage conditions, and ingredient restrictions. Regular review of new SCCS opinions allows companies to anticipate regulatory changes and adapt formulations accordingly.
Public toxicological databases such as PubChem and similar chemical information platforms offer additional safety data. These resources provide information on chemical properties, toxicological profiles, and hazard classifications. They support early-stage risk assessment and screening, especially for new or less commonly used ingredients.
Monitoring Regulatory Changes and Emerging Risks
Cosmetic ingredient regulations evolve rapidly, making active monitoring essential. Companies must track emerging scientific concerns and policy developments to avoid compliance risks.
Regulatory authorities increasingly focus on substances such as endocrine disruptors and per- and polyfluoroalkyl substances (PFAS). Early identification of these trends allows manufacturers to take corrective action before formal restrictions take effect.
Subscribing to official publications and regulatory news from the European Commission, national competent authorities, and international agencies helps companies stay informed about draft legislation and final regulatory updates. Industry associations and regulatory consultancies also provide summarized and interpreted updates that translate complex legal changes into practical guidance.
Building a Continuous Ingredient Monitoring Strategy
Effective ingredient monitoring requires an ongoing and structured process. Companies must combine mandatory checks against official regulatory databases with continuous review of scientific safety information and regulatory developments. This integrated approach enables manufacturers and Responsible Persons to maintain compliance, anticipate regulatory changes, and ensure the continued safety of cosmetic products placed on the market.
The sources worth monitoring
Ingredient compliance is a moving target, and a formulation that was compliant at launch can become illegal without anything about it changing. Monitoring does not require a large apparatus — it requires knowing which four sources actually matter and checking them on a schedule.
CosIng, the European Commission’s cosmetic ingredient database, is the practical starting point. It gives the INCI name, function and current regulatory status of a substance, including whether it appears in an Annex and under what conditions. It reflects the legislation rather than replacing it, so it is a lookup tool rather than a legal source.
SCCS opinions are the leading indicator. The Scientific Committee on Consumer Safety publishes opinions well before the Commission amends an Annex, so an unfavourable opinion on a preservative or UV filter is an early warning that a restriction is coming — usually with enough lead time to reformulate deliberately rather than urgently.
The Official Journal of the European Union carries the amending regulations themselves, with the transition dates that actually bind you. Safety Gate, the EU rapid alert system, shows which cosmetic products are being withdrawn across Member States and why — a useful signal of where enforcement attention is currently focused.
Building a monitoring routine that works
The failure mode is not ignorance of the sources; it is having no structured way of connecting a regulatory change to the specific products it affects. Two things make that connection possible.
The first is a consolidated ingredient inventory: a single list of every INCI name used across your entire portfolio, mapped to the products and the suppliers it comes from. Without it, assessing the impact of a restriction means opening every formulation individually. With it, the question takes minutes.
The second is a fixed review cadence with a named owner. A quarterly check of the Annex amendments and SCCS opinions against that inventory is enough for most portfolios, supplemented by an immediate check whenever a supplier notifies a specification change. Recording each review — date, sources checked, conclusion — turns monitoring into evidence of diligence rather than an informal habit.
What to do when an ingredient is restricted
Amending regulations normally set two dates: one after which non-compliant products may no longer be placed on the market, and a later one after which they may no longer be made available to consumers. The gap between them is your sell-through window, and planning starts from those dates working backwards.
The work itself is rarely just a formulation swap. Reformulating changes the product, which means the stability and preservative efficacy data may no longer apply, the safety assessment has to be revisited, the ingredient list on the label changes, and the CPNP notification must be updated. Artwork lead times and existing stock then determine whether the deadline is comfortable or tight.
This is why the SCCS opinion, rather than the published regulation, is the point at which a well-run compliance function starts moving. Reacting at the opinion stage usually leaves a year or more to reformulate in an orderly way; reacting when the amendment is published often does not.
Frequently asked questions
Is CosIng legally binding?
No. CosIng is an information database maintained by the Commission. The binding text is the Regulation and its Annexes as published in the Official Journal. CosIng is the fastest way to check a substance, but the consolidated legal text governs.
Who is responsible for monitoring — the brand or the manufacturer?
Legally, the Responsible Person. Contract manufacturers and suppliers often flag changes as a service, but the obligation to keep the product compliant and the Product Information File current sits with the Responsible Person named on the label.
How much notice do restrictions usually give?
It varies, but transition periods of roughly six to eighteen months between publication and the placing-on-market deadline are typical, with a further window for stock already on the market. Tracking SCCS opinions extends that warning considerably.
Do I need to update the CPNP notification after reformulating?
Yes. The notification must reflect the product as it is actually placed on the market, so a formulation change means updating the entry — particularly where the change affects the frame formulation or the information available to poison centres.
Stay ahead of ingredient restrictions and regulatory updates. Get professional monitoring support now. Contact us!
